Novonesis

Lyngby, Denmark Founded: 2023 • Age: 3 yrs Listed
Biosolutions rooted in biology are developed to address global challenges.

About Novonesis

Novonesis is a publicly listed company based in Lyngby (Denmark) founded in 2023. Biosolutions rooted in biology are developed to address global challenges. The company has 10,580 employees. Its chief executive, as recorded, is Ester Baiget. Its website novonesis.com draws about 130 thousand monthly visits. Its focus areas include Chemicals and Materials Tech, Chemicals Tech, Green Chemicals and Catalysts.

Company details

Novonesis was founded in 2023 in Lyngby, Denmark, through a combination involving Novozymes. Biosolutions based on biological sciences are created by the company to tackle challenges in production and consumption. Operations emphasize innovations for healthier living, support for greener industries, and advancements in planetary sustainability. The sector involves science-driven applications across various global domains.

  • Headquarters Lyngby, Denmark
  • Employees 10,580
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Website category Jobs and Career · Jobs and Employment
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website novonesis.com
  • Social LinkedIn X Facebook
  • Legal Name Novonesis A/S Class B
Key Metrics
  • Annual Revenue
    $4.88 B (USD)
    8.52
    as on Dec 31, 2025
  • Net Profit
    $685.91 M (USD)
    90.96
    as on Dec 31, 2025
  • EBITDA
    $1.72 B (USD)
    24.09
    as on Dec 31, 2025
  • Employee Count
    10,580

People of Novonesis

626 people are tracked at Novonesis (211 in leadership, 415 in team); the tracked headcount is 10,580.

NameRoleGroup
Ester Baiget
CEOLeadership
Ulrich Lund
Head Of P&o Core Delivery, DenmarkLeadership
Gaëtan Mulliez
Sales Director / Business Manager France & BeneluxLeadership
Pelle Clapp
Legal Business Partner LeadLeadership
Jens Erik Nielsen
Senior Vice PresidentLeadership
Alejandro González
Head Of Software DevelopmentLeadership
Sowmya Shresth
Head Of People & Organization MEIALeadership
Louise Christensen
Head Of Roskilde QC And LIMS OperationsLeadership
Peter Eskild Jensen
Senior DirectorLeadership
Ditte Arltoft
Director, Global Product SafetyLeadership
Dr. Eng. Klaus Pellicer Alborch
Senior CMO SpecialistLeadership
Wynne Lewis
Head Of Service Excellence & TransformationLeadership
Mads Mourier
Director Global Regulatory Affairs, HHC & Industrial + Global Regulatory AdvocacyLeadership
Jesper Deela Nielsen
Director, Global Procurement Head Of Logistics & PackagingLeadership
Timothy Wallace
Head, Scouting & Assessment, Ventures & External InnovationLeadership
Peter Steen Mortensen
Director, Head Of Public AffairsLeadership
Morten Anderskov
Head Of Digital Solutions & DevelopmentLeadership
Camila Lisboa Haiducki
Head Of Technical Services, LatamLeadership
Claus Crone Fuglsang
Chief Scientific Officer, Executive Vice President, NovonesisLeadership
Helge Christensen
Head Of Facility ServiceLeadership

606 more people are available in the full profile.

Premium access

Complete people profiles for Novonesis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Novonesis

Novonesis is a publicly listed company on the OMXCOP with ticker symbol NSIS_B in Denmark, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date23 Mar 2018
  • Listed onVIE: NZYM
  • Listed entityNovonesis A/S Class B
  • Exchange sectorProcess industries
  • ISINDK0060336014
  • Share price444.00 DKK (+0.34% on the day) · 2026-10-14
  • Market capitalisation206,328,133,576.00 DKK
  • Price to earnings44.0
  • EPS (diluted, trailing year)10.09 DKK
  • Dividend yield1.51%
  • Volume (last session)8,823

Financials of Novonesis

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202531.03B DKK4.36B DKK10.92B DKK
202428.59B DKK2.28B DKK8.80B DKK
202317.90B DKK3.02B DKK5.86B DKK
202217.55B DKK3.68B DKK5.81B DKK
202114.95B DKK3.15B DKK5.28B DKK
Premium access

Detailed financial statements for Novonesis

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Novonesis

The website of Novonesis (novonesis.com) receives about 129.9K visits a month and ranks #300,851 among all websites worldwide, #4,431 in Jobs and Employment.

  • Monthly visits
    129.9K

    ▲ 0.8% vs previous month

  • Unique visitors
    54.3K

    per month

  • Global rank
    #300,851

    among all websites

  • Category rank
    #4,431

    Jobs and Career · Jobs and Employment

Similar websites

Websites whose visitors overlap most with Novonesis. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
jobindex.dk
100%
2.8M#22,186View details
careerjet.dk
careerjet.dk
94%
#691,862–
englishjobs.dk
englishjobs.dk
94%
#485,155–
techjob.dk
techjob.dk
94%
#1,111,930–
dsm-firmenich.com
94%
502.3K#110,517View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Novonesis

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Novonesis

Premium access

Complete news archive for Novonesis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Novonesis

Novonesis was founded in 2023.

Novonesis is headquartered in Lyngby, Denmark. It is registered at Lyngby, Region Hovedstaden, Denmark.

Ester Baiget is the CEO of Novonesis, as recorded in our data.

Novonesis has 10,580 employees.

Annual revenue of Novonesis is $4.88B as on Dec 31, 2025.

Novonesis was founded in 2023 in Lyngby, Denmark, through a combination involving Novozymes. Biosolutions based on biological sciences are created by the company to tackle challenges in production and consumption. Operations emphasize innovations for healthier living, support for greener industries, and advancements in planetary sustainability. The sector involves science-driven applications across various global domains.

Yes, Novonesis is publicly traded on OMXCOP under the ticker symbol NSIS_B.

The website of Novonesis receives about 130 thousand visits a month and ranks #300,851 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available